MRK
Merck & Co., Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$150.67
−1.10%Margins
Gross margin
75.4%
EBITDA margin
20.8%
EBIT margin
16.7%
Net margin
4.8%
FCF margin
24.2%
7.6%
Return on equity
2.4%
Return on assets
11.5%
Return on invested capital
0.51x
Asset turnover
$20.0B
Cash from operations
$2.89
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026